Cargando…

Anticoagulant Treatment in Severe ARDS COVID-19 Patients

Patients with COVID-19 may complicate their evolution with thromboembolic events. Incidence of thromboembolic complications are high and also, patients with the critically-ill disease showed evidence of microthrombi and microangiopathy in the lung probably due to endothelial damage by directly and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceccato, Adrian, Camprubí-Rimblas, Marta, Campaña-Duel, Elena, Areny-Balagueró, Aina, Morales-Quinteros, Luis, Artigas, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148112/ https://www.ncbi.nlm.nih.gov/pubmed/35628822 http://dx.doi.org/10.3390/jcm11102695

Ejemplares similares

Bioengineered extracellular vesicles: future of precision medicine for sepsis
por: Areny-Balagueró, Aina, et al.
Publicado: (2023)

Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2023)

Fluorescent PLGA Nanocarriers for Pulmonary Administration: Influence of the Surface Charge
por: Areny-Balagueró, Aina, et al.
Publicado: (2022)

The role of hypercapnia in acute respiratory failure
por: Morales-Quinteros, Luis, et al.
Publicado: (2019)

Estimated dead space fraction and the ventilatory ratio are associated with mortality in early ARDS
por: Morales-Quinteros, Luis, et al.
Publicado: (2019)

Comparison of direct and indirect models of early induced acute lung injury
por: Chimenti, Laura, et al.
Publicado: (2020)

Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats
por: Guillamat-Prats, Raquel, et al.
Publicado: (2020)

Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS
por: Morales-Quinteros, Luis, et al.
Publicado: (2021)

Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
por: Chimenti, Laura, et al.
Publicado: (2017)

Methotrexate Ameliorates Systemic Inflammation and Septic Associated-Lung Damage in a Cecal Ligation and Puncture Septic Rat Model
por: Bringué, Josep, et al.
Publicado: (2021)

A long-lasting porcine model of ARDS caused by pneumonia and ventilator-induced lung injury
por: Barbeta, Enric, et al.
Publicado: (2023)

Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats
por: Camprubí‐Rimblas, Marta, et al.
Publicado: (2020)

Lung Extracellular Matrix Hydrogels Enhance Preservation of Type II Phenotype in Primary Alveolar Epithelial Cells
por: Marhuenda, Esther, et al.
Publicado: (2022)

Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury
por: Camprubí–Rimblas, Marta, et al.
Publicado: (2017)

Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure
por: Morales-Quinteros, Luis, et al.
Publicado: (2019)

Awake prone positioning in nonintubated spontaneous breathing ICU patients with acute hypoxemic respiratory failure (PRONELIFE)—protocol for a randomized clinical trial
por: Morales-Quinteros, L., et al.
Publicado: (2022)

Effect of the alveolar type ii cells transplantation for the treatment of acute lung injury
por: Guillamat-Prats, R, et al.
Publicado: (2015)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020)

The COVID-19 challenge. What have we learned?
por: Ceccato, Adrian, et al.
Publicado: (2022)

Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
por: Motos, Ana, et al.
Publicado: (2023)

Heparin effect in alveolar cells and macrophages in an acute lung injury model
por: Camprubí-Rimblas, M, et al.
Publicado: (2015)

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS
por: Ferrando, Carlos, et al.
Publicado: (2020)

Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS
por: Ferrando, Carlos, et al.
Publicado: (2020)

Bivalirudin Anticoagulation in Extracorporeal Membrane Oxygenation (ECMO) for Severe Coronaviral Disease (COVID-19) Related Acute Respiratory Distress Syndrome (ARDS)
por: Kumar, S., et al.
Publicado: (2022)

Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment
por: Lim, Michelle J., et al.
Publicado: (2023)

Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID–19---insights from the PRoVENT–COVID study
por: Tsonas, Anissa M., et al.
Publicado: (2022)

Cirugía ginecológica transvaginal y laparoscópica : técnicas integradas
por: Balagueró, Lorenzo
Publicado: (1996)

Prognostic factors in severe ARDS-patients
por: Friess, U, et al.
Publicado: (2000)

Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States: The Severe ARDS: Generating Evidence Study
por: Qadir, Nida, et al.
Publicado: (2021)

Lung transplantation for severe COVID-19-related ARDS
por: Ko, Ryoung-Eun, et al.
Publicado: (2022)

Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary
por: Patel, Sankalp P., et al.
Publicado: (2022)

Non-surgical management of urinary incontinence in children
por: Duel, Barry
Publicado: (2009)

Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017)

Rickettsia typhi infection presenting as severe ARDS
por: Tran, Liem T., et al.
Publicado: (2019)

Severe Covid-19 disease: rather AVDS than ARDS?
por: Mahjoub, Yazine, et al.
Publicado: (2020)

How severe COVID-19 infection is changing ARDS management
por: Ferguson, Niall D., et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
por: Camprubí, Daniel, et al.
Publicado: (2021)

Flexible bronchoscopy-related safety in patients with severe ARDS
por: Guillon, A., et al.
Publicado: (2018)

Severe ARDS Complicating an Acute Intentional Cresol Poisoning
por: Doughmi, Djoudline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_86gd6petrjgqatgvfder2vb2h1